Page last updated: 2024-09-04

fidarestat and Inflammatory Response Syndrome, Systemic

fidarestat has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hibi, C; Inaba, W; Kamata, K; Kato, N; Mizukami, H; Takahashi, K; Yagihashi, S	1

Other Studies

1 other study(ies) available for fidarestat and Inflammatory Response Syndrome, Systemic

Article	Year
Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. PloS one, 2012, Volume: 7, Issue:1 Topics: Acute Kidney Injury; Aldehyde Reductase; Animals; Apoptosis; Blotting, Western; Cytokines; Gene Expression Regulation; Imidazolidines; Kidney; Kidney Tubules; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Organ Specificity; Polymers; RNA, Messenger; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors	2012

Article

Year

Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.

PloS one, 2012, Volume: 7, Issue:1

Topics: Acute Kidney Injury; Aldehyde Reductase; Animals; Apoptosis; Blotting, Western; Cytokines; Gene Expression Regulation; Imidazolidines; Kidney; Kidney Tubules; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Organ Specificity; Polymers; RNA, Messenger; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors

2012